Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent Tuberculosis
Authors:
- Frangiscos SifakisFSFrangiscos Sifakis
- Ruben Montes de OcaRORuben Montes de Oca
- Wendy A. CroninWCWendy A. Cronin
- Meg C. DohertyMDMeg C. Doherty
- Lynn FederlineLFLynn Federline
- Sarah BurSBSarah Bur
- Thomas WalshTWThomas Walsh
- Walter KarneyWKWalter Karney
- James MilmanJMJames Milman
- Nancy BaruchNBNancy Baruch
- Akintoye AdelakunAAAkintoye Adelakun
- 25 September 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 166 (17) , 1863-1870
Abstract
Research from JAMA Internal Medicine — Improved Adherence and Less Toxicity With Rifampin vs Isoniazid for Treatment of Latent Tuberculosis — A Retrospective StudyKeywords
This publication has 11 references indexed in Scilit:
- The Research on Adverse Drug Events and Reports (RADAR) ProjectJAMA, 2005
- Considering the Role of Four Months of Rifampin in the Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Treatment Completion and Costs of a Randomized Trial of Rifampin for 4 Months versus Isoniazid for 9 MonthsAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Rifampin and Pyrazinamide for Latent Tuberculosis Infection: Clinical Trials and General PracticeClinical Infectious Diseases, 2004
- Use of Isoniazid for Latent Tuberculosis Infection in a Public Health ClinicAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Global Drug-Resistance Patterns and the Management of Latent Tuberculosis Infection in Immigrants to the United StatesNew England Journal of Medicine, 2002
- Hepatotoxicity Associated with Isoniazid Preventive Therapy: A 7-Year Survey from a Public Health Tuberculosis ClinicSurvey of Anesthesiology, 2000
- Rifampin Preventive Therapy for Tuberculosis Infection: Experience With 157 AdolescentsAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Experimental Short-course Preventive Therapy of Tuberculosis with Rifampin and PyrazinamideAmerican Review of Respiratory Disease, 1989
- The action of antituberculosis drugs in short-course chemotherapyTubercle, 1985